Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 44 studies | 47% ± 21% | |
fibroblast | 38 studies | 36% ± 13% | |
B cell | 34 studies | 32% ± 13% | |
pericyte | 28 studies | 45% ± 18% | |
endothelial cell of lymphatic vessel | 26 studies | 51% ± 20% | |
basal cell | 22 studies | 58% ± 20% | |
epithelial cell | 22 studies | 50% ± 21% | |
smooth muscle cell | 20 studies | 37% ± 15% | |
memory B cell | 20 studies | 35% ± 10% | |
naive B cell | 20 studies | 30% ± 9% | |
ciliated cell | 18 studies | 54% ± 18% | |
endothelial cell of artery | 15 studies | 51% ± 16% | |
endothelial cell of vascular tree | 15 studies | 63% ± 23% | |
capillary endothelial cell | 14 studies | 50% ± 18% | |
vein endothelial cell | 14 studies | 56% ± 21% | |
type I pneumocyte | 11 studies | 33% ± 17% | |
secretory cell | 11 studies | 47% ± 18% | |
connective tissue cell | 11 studies | 37% ± 19% | |
myofibroblast cell | 11 studies | 52% ± 18% | |
goblet cell | 11 studies | 47% ± 19% | |
type II pneumocyte | 10 studies | 39% ± 19% | |
plasma cell | 9 studies | 29% ± 11% | |
platelet | 9 studies | 57% ± 15% | |
plasmablast | 8 studies | 42% ± 22% | |
progenitor cell | 8 studies | 42% ± 20% | |
enterocyte | 8 studies | 50% ± 21% | |
abnormal cell | 7 studies | 30% ± 14% | |
precursor B cell | 7 studies | 46% ± 13% | |
alveolar macrophage | 6 studies | 34% ± 12% | |
club cell | 6 studies | 53% ± 11% | |
respiratory goblet cell | 6 studies | 45% ± 23% | |
megakaryocyte | 6 studies | 78% ± 26% | |
immature B cell | 6 studies | 49% ± 17% | |
hematopoietic precursor cell | 5 studies | 30% ± 8% | |
transit amplifying cell | 5 studies | 52% ± 22% | |
pro-B cell | 5 studies | 35% ± 7% | |
brush cell | 5 studies | 36% ± 18% | |
cardiac muscle cell | 5 studies | 21% ± 5% | |
natural killer cell | 5 studies | 19% ± 3% | |
hematopoietic stem cell | 5 studies | 39% ± 16% | |
deuterosomal cell | 4 studies | 49% ± 14% | |
pancreatic A cell | 4 studies | 45% ± 18% | |
endothelial cell of sinusoid | 4 studies | 30% ± 11% | |
conventional dendritic cell | 4 studies | 46% ± 21% | |
glomerular endothelial cell | 4 studies | 50% ± 6% | |
enteroendocrine cell | 4 studies | 32% ± 9% | |
intestinal crypt stem cell | 4 studies | 50% ± 18% | |
adventitial cell | 4 studies | 34% ± 9% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 49% ± 13% | |
megakaryocyte-erythroid progenitor cell | 4 studies | 65% ± 19% | |
hepatocyte | 4 studies | 38% ± 20% | |
keratinocyte | 4 studies | 35% ± 5% | |
duct epithelial cell | 3 studies | 53% ± 9% | |
ionocyte | 3 studies | 36% ± 7% | |
squamous epithelial cell | 3 studies | 34% ± 24% | |
type B pancreatic cell | 3 studies | 45% ± 8% | |
placental villous trophoblast | 3 studies | 57% ± 28% | |
retinal cone cell | 3 studies | 23% ± 2% | |
mesothelial cell | 3 studies | 18% ± 3% | |
macrophage | 3 studies | 49% ± 27% | |
dendritic cell | 3 studies | 34% ± 8% | |
pancreatic ductal cell | 3 studies | 66% ± 11% | |
myoepithelial cell | 3 studies | 51% ± 21% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 14 studies | 39% ± 18% | |
intestine | 10 studies | 34% ± 17% | |
pancreas | 4 studies | 42% ± 15% | |
heart | 4 studies | 19% ± 2% | |
uterus | 4 studies | 43% ± 15% | |
breast | 4 studies | 29% ± 8% | |
placenta | 3 studies | 33% ± 14% | |
eye | 3 studies | 18% ± 1% | |
esophagus | 3 studies | 37% ± 16% | |
prostate | 3 studies | 49% ± 11% | |
bone marrow | 3 studies | 21% ± 4% | |
skin | 3 studies | 28% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 7584.97 | 358 / 359 | 100% | 349.81 | 286 / 286 |
bladder | 100% | 11242.33 | 21 / 21 | 99% | 374.09 | 501 / 504 |
thymus | 100% | 13961.45 | 653 / 653 | 99% | 578.15 | 601 / 605 |
lung | 100% | 21858.50 | 578 / 578 | 99% | 283.56 | 1145 / 1155 |
esophagus | 99% | 8286.62 | 1429 / 1445 | 100% | 372.81 | 183 / 183 |
intestine | 98% | 11441.34 | 951 / 966 | 100% | 367.78 | 526 / 527 |
uterus | 100% | 8291.44 | 170 / 170 | 96% | 373.03 | 442 / 459 |
liver | 99% | 4843.88 | 224 / 226 | 97% | 196.60 | 393 / 406 |
breast | 100% | 16230.30 | 459 / 459 | 92% | 216.27 | 1030 / 1118 |
prostate | 99% | 8176.87 | 243 / 245 | 81% | 94.87 | 409 / 502 |
pancreas | 82% | 3487.02 | 269 / 328 | 98% | 308.56 | 175 / 178 |
kidney | 85% | 4994.98 | 76 / 89 | 89% | 225.57 | 804 / 901 |
skin | 100% | 8717.79 | 1808 / 1809 | 41% | 41.92 | 194 / 472 |
ovary | 35% | 1557.46 | 63 / 180 | 98% | 212.85 | 420 / 430 |
adipose | 100% | 17783.06 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 9783.72 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 384.14 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 213.66 | 1 / 1 |
blood vessel | 100% | 16070.78 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 25267.45 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 13012.06 | 852 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 41% | 1223.00 | 105 / 258 | 56% | 93.05 | 129 / 230 |
lymph node | 0% | 0 | 0 / 0 | 97% | 201.64 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 61% | 65.36 | 49 / 80 |
peripheral blood | 31% | 5900.54 | 285 / 929 | 0% | 0 | 0 / 0 |
brain | 3% | 106.56 | 75 / 2642 | 16% | 15.57 | 114 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030011 | Biological process | maintenance of cell polarity |
GO_0007507 | Biological process | heart development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0061061 | Biological process | muscle structure development |
GO_0010761 | Biological process | fibroblast migration |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0001666 | Biological process | response to hypoxia |
GO_0030950 | Biological process | establishment or maintenance of actin cytoskeleton polarity |
GO_0043149 | Biological process | stress fiber assembly |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0006979 | Biological process | response to oxidative stress |
GO_0005856 | Cellular component | cytoskeleton |
GO_0031941 | Cellular component | filamentous actin |
GO_0030018 | Cellular component | Z disc |
GO_0005925 | Cellular component | focal adhesion |
GO_0001725 | Cellular component | stress fiber |
GO_0005912 | Cellular component | adherens junction |
GO_0005737 | Cellular component | cytoplasm |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0051371 | Molecular function | muscle alpha-actinin binding |
GO_0098641 | Molecular function | cadherin binding involved in cell-cell adhesion |
GO_0046872 | Molecular function | metal ion binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | PDLIM1 |
Protein name | Epididymis secretory protein Li 112 (PDZ and LIM domain 1 (Elfin), isoform CRA_a) PDZ and LIM domain protein 1 (C-terminal LIM domain protein 1) (Elfin) (LIM domain protein CLP-36) |
Synonyms | HEL-S-112 CLP36 CLIM1 hCG_39492 |
Description | FUNCTION: Cytoskeletal protein that may act as an adapter that brings other proteins (like kinases) to the cytoskeleton . Involved in assembly, disassembly and directioning of stress fibers in fibroblasts. Required for the localization of ACTN1 and PALLD to stress fibers. Required for cell migration and in maintaining cell polarity of fibroblasts (By similarity). . |
Accessions | ENST00000329399.7 O00151 V9HW92 |